Sickle cell disease: the neurological complications

Area of Science:

• Neurology
• Hematology
• Genetics

Background:

• The genetic basis of sickle cell disease (SCD) is known, but its clinical variability, particularly neurological complications, remains poorly understood.
• Neurological issues in SCD stem from a single point mutation causing vasculopathy, anemia, and hemodynamic insufficiency.
• Sickled cells contribute to thrombus formation and impaired compensatory mechanisms in cerebral vessels.

Purpose of the Study:

• To explore the underlying mechanisms of neurological complications in sickle cell disease.
• To investigate the factors contributing to stroke risk in patients with SCD.
• To understand the interplay between genetic, environmental, and molecular factors in cerebrovascular disease.

Main Methods:

• Analysis of pathological mechanisms including vasculopathy, hemodynamic insufficiency, and endothelial adhesion.
• Examination of the role of nitric oxide deficiency and small-vessel sludging.
• Review of evidence for clinical strokes, silent infarcts, and contributing risk factors.

Main Results:

• Sickle cell disease causes vasculopathy, anemia, and impaired cerebrovascular reserve, leading to strokes and cognitive deficits.
• Environmental factors like hypoxia and inflammation, along with genetic factors promoting thrombogenesis, increase stroke risk.
• Sickle cell disease serves as a model for understanding polygenic cerebrovascular disease.

Conclusions:

• Neurological complications in SCD are multifactorial, involving vascular damage, anemia, and limited compensatory mechanisms.
• Stroke risk in SCD is influenced by a combination of disease-specific factors and additional genetic and environmental modifiers.
• Bridging the gap between molecular genetics and clinical therapeutics is crucial for managing SCD-related cerebrovascular disease.